Par Drugs & Che.

68
Hold
  • Market Cap: Micro Cap
  • Industry: Chemicals & Petrochemicals
  • ISIN: INE04LG01015
  • NSEID: PAR
  • BSEID:
INR
136.60
3.06 (2.29%)
BSENSE

Sep 18, 03:30 PM

BSE+NSE Vol: 29278

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 2.66% vs 5.58% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is -12.15% vs -14.53% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is 55.05% vs -23.34% in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is -1.87% vs -7.88% in Mar 2025

Compare Profit and Loss Results of Par Drugs & Che.
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
116.00
799.00
-683.00
-85.48%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
12.00
0.00
12.00
0%
Net Sales
103.00
799.00
-696.00
-87.11%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
7.00
-7.00
-100.00%
Raw Materials Consumed
42.00
720.00
-678.00
-94.17%
Power & Fuel Cost
18.00
2.00
16.00
800.00%
Employee Cost
6.00
6.00
0.00
0.00%
Operating Expenses
6.00
4.00
2.00
50.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
9.00
35.00
-26.00
-74.29%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
86.00
781.00
-695.00
-88.99%
Operating Profit (PBDIT) excl Other Income
17.00
17.00
0.00
0.00%
Other Income
4.00
1.00
3.00
300.00%
Operating Profit (PBDIT)
21.00
18.00
3.00
16.67%
Interest
0.00
3.00
-3.00
-100.00%
Profit before Depriciation and Tax
21.00
14.00
7.00
50.00%
Depreciation
3.00
1.00
2.00
200.00%
Profit Before Taxation & Exceptional Items
17.00
13.00
4.00
30.77%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
17.00
13.00
4.00
30.77%
Provision for Tax
4.00
3.00
1.00
33.33%
Profit After Tax
13.00
9.00
4.00
44.44%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
75.00
62.00
13.00
20.97%
Profit Available for appropriations
89.00
72.00
17.00
23.61%
Appropriations
89.00
72.00
17.00
23.61%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
10.65
4.14
6.51
157.25%
Profit And Loss - Net Sales
Net Sales 103.66 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 2.66% vs 5.58% in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 17.13 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -12.15% vs -14.53% in Mar 2025

Profit And Loss - Interest
Interest 0.13 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 55.05% vs -23.34% in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax 13.11 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -1.87% vs -7.88% in Mar 2025